SARS-CoV-2 IgG/IgM Rapid Qualitative Test

Product Description

The SARS-CoV*2 IgG/IgM Rapid Qualitative Test is a lateral flow immunoassay intended for the qualitative detection. The SARS-CoV*2 IgG/IgM Rapid Qualitative Test is intended for use as an aid in identifying individuals with an adaptive immune response to SARS-CoV*2, indicating recent or prior infection. IgM and IgG antibodies to SARS-CoV*2 are generally detectable in blood several days after initial infection.
Biotime SARS-CoV*2 IgG/IgM Rapid Qualitative Test is easy to use and suit for one step test, two results come within *5 minutes. It can be used as a powerful supplement for nucleic acid test. Biotime SARS-CoV*2 IgG/IgM Rapid Qualitative Test supports samples for whole blood, serum or plasma and has different packaging specifications. 
Biotime SARS-CoV*2 IgG/IgM Rapid Qualitative Test has been done lots of verification experiments in domestic and foreign clinical and research institutions. Besides, it has got many registration certificate including CE, MHRA, Russia, Ukraine, Brazil, Philippines, Ecuador, Chile and Honduras, Nigeria, etc, and it has been sold into different countries such as Germany, France, UK , Brazil and Philippines, etc. Also, we have obtained emergency authorization from the US FDA.